(Reuters) - Gardasil vaccinates against a virus responsible for causing cervical cancer. The company said the U.S. Food and Drug Administration will determine whether it will accept Merck's new application for review within 60 days of its submission.
Read more at Reuters.com Market News
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment